About Apionex Pharma Private Limited
Data last updated:
Apionex Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 05 October 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U33209MH2018PTC315329. Its GSTIN is 27AARCA4261F1ZK (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Nirav Vinod Shah and Nikita Nirav Shah (Director Appointed In Casual Vacancy).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1206 Plot No 856 Ghanshyam Enclave Link Road Lalji Pada Kandivali (West), Mumbai, Maharashtra, India – 400067.
As per the financials filed for FY 2024, the company reported a revenue of ₹17.29 Cr, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹65.51 Lakh (net margin 3.8%) and EBITDA of ₹97.26 Lakh (EBITDA margin 5.6%). Revenue has grown at a compounded annual rate (CAGR) of 31% over three years and 236% over five years.
The company is associated with 1 brand: Apionex. As per MCA filings, the company has open charges of ₹3.93 Cr on record.
For more details, the company can be reached via its website apionex.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address1206 Plot No 856 Ghanshyam Enclave Link Road Lalji Pada Kandivali (West), Mumbai, Maharashtra, India – 400067
- IndustryPharma, API Manufacturers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Apionex Pharma Private Limited
Apionex Pharma operates one associated brand: Apionex. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing of active pharmaceutical ingredients and contract-based molecule development services. | apionex.com |
Business Activity of Apionex Pharma Private Limited
The main business activity of Apionex Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Apionex Pharma Private Limited
Apionex Pharma Private Limited is audited by NIRAJ SANGHAVI & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| NIRAJ SANGHAVI & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Apionex Pharma Private Limited
Apionex Pharma has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nirav Vinod Shah Also directs: Enolic Pharma Private Limited | Director | 05 Oct 2018 | 8 Years 0 Months | Current |
| Nikita Nirav Shah Also directs: Enolic Pharma Private Limited | Director Appointed In Casual Vacancy | 09 Dec 2024 | 1 Years 9 Months | Current |
| Chintal Tejas Laliwala | Additional Director | 11 Dec 2024 | 1 Years 9 Months | Current |
Financials of Apionex Pharma Private Limited FY 2025 filings available
Apionex Pharma Private Limited reported revenue of ₹17.29 Cr (up 5% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Apionex Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 236% over five years, including 5% growth in the latest year. EBITDA rose 35% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Apionex Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹97.26 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹65.51 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Apionex Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Apionex Pharma are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Apionex Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Apionex Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 May 2025 | Hdfc Bank Limited | ₹18 Lakh | Open |
| 29 Jan 2022 | Hdfc Bank Limited | ₹3.75 Cr | Open |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Apionex Pharma Private Limited
Employment history and EPFO contributions of people linked to Apionex Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Apionex Pharma Private Limited
Apionex Pharma has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AARCA4261F1ZK | Maharashtra | Active | 13 Dec 2018 |
| 24AARCA4261F1ZQ | Gujarat | Active | 21 May 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Apionex Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Apionex Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Apionex Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Apionex Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Apionex Pharma Private Limited
Frequently Asked Questions about Apionex Pharma Private Limited
Apionex Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 05 October 2018 (8+ years old) and is registered under CIN U33209MH2018PTC315329.
Apionex Pharma reported revenue of ₹17.29 Cr for FY 2024 (up 5% YoY).
Apionex Pharma has 3 current directors:
- Nirav Vinod Shah - Director
- Nikita Nirav Shah - Director Appointed In Casual Vacancy
- Chintal Tejas Laliwala - Additional Director
Apionex Pharma reported a net profit of ₹65.51 Lakh (net margin 3.8%) and EBITDA of ₹97.26 Lakh (EBITDA margin 5.6%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Apionex Pharma is 31% over three years and 236% over five years. In the latest year (FY 2024) revenue rose 5%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Apionex Pharma is 27AARCA4261F1ZK, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 24AARCA4261F1ZQ (Gujarat).
The CIN (Corporate Identification Number) of Apionex Pharma is U33209MH2018PTC315329. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Apionex Pharma was incorporated on 05 October 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
Apionex Pharma can be reached through the website apionex.com. Its registered office is in Mumbai, Maharashtra, India.